Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study

Systemic sclerosis (SSc) patients often present cardiovascular autonomic dysfunction, which is associated with the risk of arrhythmic complications and mortality. However, little is known regarding the progression of cardiac autonomic impairment over time. We aimed to evaluate the cardiac autonomic...

Full description

Bibliographic Details
Main Authors: Gabriel Dias Rodrigues, Angelica Carandina, Costanza Scatà, Chiara Bellocchi, Lorenzo Beretta, Pedro Paulo da Silva Soares, Eleonora Tobaldini, Nicola Montano
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/1/34
_version_ 1797439785198944256
author Gabriel Dias Rodrigues
Angelica Carandina
Costanza Scatà
Chiara Bellocchi
Lorenzo Beretta
Pedro Paulo da Silva Soares
Eleonora Tobaldini
Nicola Montano
author_facet Gabriel Dias Rodrigues
Angelica Carandina
Costanza Scatà
Chiara Bellocchi
Lorenzo Beretta
Pedro Paulo da Silva Soares
Eleonora Tobaldini
Nicola Montano
author_sort Gabriel Dias Rodrigues
collection DOAJ
description Systemic sclerosis (SSc) patients often present cardiovascular autonomic dysfunction, which is associated with the risk of arrhythmic complications and mortality. However, little is known regarding the progression of cardiac autonomic impairment over time. We aimed to evaluate the cardiac autonomic modulation among SSc with limited cutaneous (lcSSc), diffuse cutaneous (dcSSc) subset, and age-matched healthy control (HC) at baseline (t0) and five-year follow-up (t1). In this follow-up study, ECG was recorded at t0 and t1 in twenty-four SSc patients (dcSSc; <i>n</i> = 11 and lcSSc; <i>n</i> = 13) and 11 HC. The heart rate variability (HRV) analysis was conducted. The spectral analysis identified two oscillatory components, low frequency (LF) and high frequency (HF), and the sympatho-vagal balance was assessed by the LF/HF ratio. The LF/HF increased (<i>p</i> = 0.03), and HF reduced at t1 compared to t0 in dcSSc (<i>p</i> = 0.03), which did not occur in the lcSSc and HC groups. Otherwise, both lcSSc and dcSSc groups presented augmented LF/HF at t0 and t1 compared to HC (<i>p</i> < 0.01). In conclusion, a worsening of cardiac autonomic dysfunction is related to the dcSSc subset, in which a more extent of skin fibrosis and internal organs fibrosis is present.
first_indexed 2024-03-09T11:58:06Z
format Article
id doaj.art-fb7e217fb25945f48ef0ad620328c386
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T11:58:06Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-fb7e217fb25945f48ef0ad620328c3862023-11-30T23:07:03ZengMDPI AGLife2075-17292022-12-011313410.3390/life13010034Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up StudyGabriel Dias Rodrigues0Angelica Carandina1Costanza Scatà2Chiara Bellocchi3Lorenzo Beretta4Pedro Paulo da Silva Soares5Eleonora Tobaldini6Nicola Montano7Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, ItalyDepartment of Internal Medicine, Fondazione IRCC.S. Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, ItalyDepartment of Internal Medicine, Fondazione IRCC.S. Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milan, ItalyPost-Graduation Program in Cardiovascular Sciences, Fluminense Federal University, Niterói 24020-141, BrazilDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, ItalySystemic sclerosis (SSc) patients often present cardiovascular autonomic dysfunction, which is associated with the risk of arrhythmic complications and mortality. However, little is known regarding the progression of cardiac autonomic impairment over time. We aimed to evaluate the cardiac autonomic modulation among SSc with limited cutaneous (lcSSc), diffuse cutaneous (dcSSc) subset, and age-matched healthy control (HC) at baseline (t0) and five-year follow-up (t1). In this follow-up study, ECG was recorded at t0 and t1 in twenty-four SSc patients (dcSSc; <i>n</i> = 11 and lcSSc; <i>n</i> = 13) and 11 HC. The heart rate variability (HRV) analysis was conducted. The spectral analysis identified two oscillatory components, low frequency (LF) and high frequency (HF), and the sympatho-vagal balance was assessed by the LF/HF ratio. The LF/HF increased (<i>p</i> = 0.03), and HF reduced at t1 compared to t0 in dcSSc (<i>p</i> = 0.03), which did not occur in the lcSSc and HC groups. Otherwise, both lcSSc and dcSSc groups presented augmented LF/HF at t0 and t1 compared to HC (<i>p</i> < 0.01). In conclusion, a worsening of cardiac autonomic dysfunction is related to the dcSSc subset, in which a more extent of skin fibrosis and internal organs fibrosis is present.https://www.mdpi.com/2075-1729/13/1/34heart rate variabilitysclerodermaautoimmune diseasesautonomic nervous system
spellingShingle Gabriel Dias Rodrigues
Angelica Carandina
Costanza Scatà
Chiara Bellocchi
Lorenzo Beretta
Pedro Paulo da Silva Soares
Eleonora Tobaldini
Nicola Montano
Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
Life
heart rate variability
scleroderma
autoimmune diseases
autonomic nervous system
title Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
title_full Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
title_fullStr Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
title_full_unstemmed Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
title_short Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study
title_sort sympatho vagal dysfunction in systemic sclerosis a follow up study
topic heart rate variability
scleroderma
autoimmune diseases
autonomic nervous system
url https://www.mdpi.com/2075-1729/13/1/34
work_keys_str_mv AT gabrieldiasrodrigues sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT angelicacarandina sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT costanzascata sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT chiarabellocchi sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT lorenzoberetta sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT pedropaulodasilvasoares sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT eleonoratobaldini sympathovagaldysfunctioninsystemicsclerosisafollowupstudy
AT nicolamontano sympathovagaldysfunctioninsystemicsclerosisafollowupstudy